Business
Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
– CAPTAIN is the first randomized controlled trial ever comparing a new technology to the standard of care of robotic radical prostatectomy to successfully recruit to target –TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that Pejman Ghanouni, MD, PhD
About this update from Profound Medical Corp
[{"type":"image","alt":"Profound Medical Corp.","displaySize":"","headline":null,"caption":"Profound Medical Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":39,"url":"https://media.zenfs.com/en/globenewswire.com/706e95b61981393723638191940b98c5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oleh9hsLn64FmkZjOMsmoQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTU1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/706e95b61981393723638191940b98c5","width":300,"height":39}},"lazy":false},{"type":"text","content":"– CAPTAIN is the first randomized controlled trial ever comparing a new technology to the standard of care of robotic radical prostatectomy to successfully recruit to target –","length":175,"tagName":"p"},{"type":"text","content":"TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that Pejman Ghanouni, MD, PhD, Associate Professor in the Department of Radiology, Division of Body MRI at Stanford University School of Medicine, has received the Cum Laude award for his presentation titled “CAPTAIN Randomized Controlled Trial of MRI-Guided Transurethral Ultrasound Ablation (TULSA) Versus Robotic Radical Prostatectomy” at the 2025 Radiological Society of North America (“RSNA”) Annual Meeting, which just concluded today in Chicago.","length":748,"tagName":"p"},{"type":"text","content":"RSNA recognizes outstanding education exhibits at its annual meeting with awards of Magna Cum Laude, Cum Laude and Certificate of Merit. Awards are based on review by subspecialty panels within the RSNA Education Exhibits Awards Committee. Dr. Ghanouni’s poster presentation was one (1) of only six (6) that received Cum Laude Awards at RSNA 2025, representing the top 5% of the scientific posters presented at the meeting.","length":423,"tagName":"p"},{"type":"text","content":"“We would like to congratulate Dr. Ghanouni on receiving the prestigious Cum Laude award from RSNA, a significant professional achievement, as well as a testament to the fact that CAPTAIN enlisted some of the nation’s best academic physicians, which was critical for successful randomization,” said Profound CEO and Chairm...